Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-08-18 7:20 pm Purchase | 13G | UNUM THERAPEUTICS INC UMRX | Venrock Healthcare Capital Partners II L.P. | 4,355,273 11.4% | 2,468,055 (+130.78%) | View |
| 2020-07-30 7:05 pm Purchase | 13G | IMV INC IMV | Venrock Healthcare Capital Partners II L.P. | 3,150,000 5.1% | 3,150,000 (New Position) | View |
| 2020-07-20 4:07 pm Purchase | 13G | UNUM THERAPEUTICS INC UMRX | Venrock Healthcare Capital Partners II L.P. | 1,887,218 5% | 1,887,218 (New Position) | View |
| 2020-06-25 4:06 pm Purchase | 13D | ALTIMMUNE INC ALT | Venrock Healthcare Capital Partners II L.P. | 4,500,000 20.8% | 1,500,000 (+50.00%) | View |
| 2020-06-12 4:01 pm Purchase | 13G | HUMANIGEN INC HGEN | Venrock Healthcare Capital Partners II L.P. | 17,241,379 8.3% | 17,241,379 (New Position) | View |
| 2020-06-01 4:05 pm Purchase | 13G | ALTIMMUNE INC ALT | Venrock Healthcare Capital Partners II L.P. | 3,000,000 19.3% | 3,000,000 (New Position) | View |
| 2020-05-29 4:05 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | Venrock Healthcare Capital Partners II L.P. | 3,877,895 9.9% | 3,877,895 (New Position) | View |
| 2020-04-03 4:05 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners II L.P. | 0 0% | -2,215,089 (Position Closed) | View |
| 2020-02-14 4:09 pm Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Venrock Healthcare Capital Partners II L.P. | 113,140 0.4% | -1,385,989 (-92.45%) | View |
| 2020-02-14 4:08 pm Sale | 13G | OBSEVA SA COM SHS OBSV | Venrock Healthcare Capital Partners II L.P. | 2,383,903 4.9% | -1,028,346 (-30.14%) | View |
| 2020-02-14 4:08 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners II L.P. | 2,215,089 9% | 2,215,089 (New Position) | View |
| 2020-02-14 4:08 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 6,502,840 7.5% | 2,500,000 (+62.46%) | View |
| 2020-02-14 4:07 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners II L.P. | 986,173 5.5% | -1,057,939 (-51.76%) | View |
| 2020-02-14 4:07 pm Purchase | 13G | AXSOME THERAPEUTICS INC AXSM | Venrock Healthcare Capital Partners II L.P. | 2,333,975 6.3% | 693,975 (+42.32%) | View |
| 2019-12-20 8:22 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | Venrock Healthcare Capital Partners II L.P. | 2,483,903 5.2% | 2,483,903 (New Position) | View |
| 2019-12-16 5:11 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II L.P. | 882,814 6.2% | 882,814 (New Position) | View |
| 2019-12-16 4:06 pm Purchase | 13G | IVERIC BIO INC ISEE | Venrock Healthcare Capital Partners II L.P. | 2,704,096 5.6% | 2,704,096 (New Position) | View |
| 2019-11-25 4:05 pm Purchase | 13G | 89BIO INC ETNB | Venrock Healthcare Capital Partners II L.P. | 1,000,000 7.3% | 1,000,000 (New Position) | View |
| 2019-11-25 4:05 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | Venrock Healthcare Capital Partners II L.P. | 8,289,478 9.99% | 8,289,478 (New Position) | View |
| 2019-10-07 4:05 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 4,002,840 7.6% | 4,002,840 (New Position) | View |